Abstract
Over the last few years data have accumulated suggesting that there may be genetic and biologic risk factors for suicide. This paper reviews studies from clinical populations, twins, the Amish, as well as data from the Iowa-500 and Danish-American adoption studies which suggest that there may be a genetic factor predisposing to suicide. The paper also reviews neurochemical data from cerebrospinal fluid, urine and postmortem studies which suggest that diminished central serotonin and dopamine may be implicated in suicidal behavior.
Similar content being viewed by others
References
Roy, A. Suicide in Comprehensive Textbook of Psychiatry, 5th ed. Edited by Kaplan, H., Sadock, B. Baltimore, Williams and Wilkins, 1989.
Pitts, F., and Winokur, G. Affective disorder. Part II (Diagnostic correlates and incidence of suicide). Journal of Nervous and Mental Disorders,139 176–181, 1984.
Roy, A. Family history of suicide. Archives of General Psychiatry, 40, 971–974, 1983.
Linkowski, P., de Maertelaer, V., Mendlewicz, J. Suicidal behavior in major depressive illness. Acta Psychiatrica Scandinavica 72, 233–238, 1985.
Roy, A. Risk factors for suicide in psychiatric patients. Archives of General Psychiatry, 39, 1089–1095, 1982.
Roy, A. Family history of suicide in affective disorder patients. Journal of Clinical Psychiatry, 46, 317–319, 1985.
Roy, A. Genetics of suicide. In J. Mann, & M. Stanley (eds.), Psychobiology of Suicidal Behavior, pp 97–105. New York: New York Academy of Science Annals, 1986.
Roy, A. Family history of suicide in manic-depressive patients. Journal of Affective Disorders, 8, 187–189, 1985.
Tsuang, M. Risk of suicide in the relatives of schizophrenics, manics, depressives, and controls. Journal of Clinical Psychiatry, 44, 396–400, 1983.
Roy, A. Segal, N., Centerwall, B. Robinette, D. Suicide in twins. Archives of General Psychiatry, 48, 29–32, 1991.
Haberlandt, W. Aportacion a la genetica del suicide. Folia Clinica Int, 17, 319–322, 1967.
Haberlandt, W. Der suizid als genetisches problem (zwilling and familien analyse). Anthropologischer Anzeiger, 29, 65–89, 1965.
Juel-Nielsen, N. Videbech, T. A twin study of suicide. Acta Geneticae Medicae et Gemellologiae (Roma), 19, 307–310, 1970.
Zaw, K. A suicidal family. British Journal of Psychiatry, 189, 68–69, 1981.
Egeland, J. Sussex, J. Suicide and family loading for affective disorders. Journal of the American Medical Association, 254, 915–918, 1985.
Schulsinger, F., Kety, S., Rosenthal, D. Wender, P. (1979). A family study of suicide. In M. Schou, & E. Stromgren (eds.), Origins, Prevention and Treatment of Affective Disorders, pp. 277–287. New York: Academic Press.
Wender, P., Kety, Rosenthal, D., Schulsinger, F., Ortmann, J. Lunde, I. Psychiatric disorders in the biological and adaptive families of adopted individuals with affective disorders. Archives of General Psychiatry, 43, 923–929, 1986.
Kety, S. Genetic factors in suicide. In A. Roy (ed.), Suicide, pp. 41–45. Baltimore, MD: Williams & Wilkins, 1986.
Asberg, M., Traskman, L. Thoren, P., 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Archives of General Psychiatry, 33, 1193–1197, 1976.
van Praag, H. Depression, suicide and the metabolism of serotonin in the brain. Journal of Affective Disorders, 4, 275–290, 1982.
Roy, A. Linnoila, M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatrica Scandinavica, 78, 529–535, 1988.
Traskman, L., Asberg, M., Bertilsson, L., Sjostrand, L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry, 38, 631–636, 1981.
Banki, C., Arato, M., Papp, Z., Kurez, M. Biochemical markers in suicidal patients: investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. Journal of Affective Disorders, 6, 341–350, 1984.
Stanley, M., Mann, J. & Cohen, S. Serotonin and serotonergic receptors in suicide. In Psychobiology of Suicidal Behavior. (pp. 122–127). New York: Annals of New York, 1986. Academy of Sciences.
Agren, H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid, II: suicide. Psychiatry Research, 3, 225–236, 1980.
Montgomery, S., Montgomery, D. Pharmacological prevention of suicidal behavior. Journal of Affective Disorders, 4, 291–298, 1982.
Roy, A. Agren, H., Pickar, D., Linnoila, M., Doran, A., Cutler, N., Paul, S. Reduced CSF concentration of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. American Journal of Psychiatry, 143, 1539–1545, 1986.
Roy, A., DeJong J. Linnoila, M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. Archives of General Psychiatry, 46, 609–612, 1989.
Roy, A. Marked reductions in indexes of dopamine metabolism among patients with depression who attempt suicide: Archives of General Psychiatry. 49, 447–450, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roy, A. Genetic and biologic risk factors for suicide in depressive disorders. Psych Quart 64, 345–358 (1993). https://doi.org/10.1007/BF01064927
Issue Date:
DOI: https://doi.org/10.1007/BF01064927